Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
    • Mains Master Notes
    • PYQ Mastery Program
  • Portal Login
    • Home
    • About Us
    • Courses
      • Prelims Test Series
        • LAQSHYA 2026 Prelims Mentorship
      • Mains Mentorship
        • Arjuna 2026 Mains Mentorship
      • Mains Master Notes
      • PYQ Mastery Program
    • Portal Login

    Misconception drives under-prescription of ORS

    • February 10, 2024
    • Posted by: OptimizeIAS Team
    • Category: DPN Topics
    No Comments

     

     

    Misconception drives under-prescription of ORS

    Subject: Science and tech

    Section: Health

    Oral Rehydration Salts (ORS)

    • It involves drinking water with modest amounts of sugar and salts, specifically sodium and potassium.
    • It is on the World Health Organization’s List of Essential Medicines. Globally oral rehydration therapy is used by approx. 41% of children with diarrhoea.
    • Its use has played an important role in reducing the number of deaths in children under the age of five.
    • Oral rehydration therapy (ORT) is a type of fluid replacement used to prevent and treat
    • dehydration, especially due to diarrhea, decreases the risk of death from diarrhea by up to 93%.

    What is misconception here:

    • Healthcare providers assume that patients do not want ORS and this led to under-prescription.
    • Oral Rehydration Salts (ORS) are a lifesaving and inexpensive treatment for diarrhoea in children, but few prescribe it in developing countries especially.
    • However, presently, nearly half of diarrhoeal cases around the world do not receive ORS, according to researchers.
    • As per a randomised controlled trial to simultaneously study the role of three leading explanations for under-prescribing of ORS are as :
    1. Providers might think patients prefer non-ORS treatments such as antibiotics or dislike ORS because of poor taste and perceptions that ORS is not a real medicine.
    2. Providers could be responding to financial incentives to sell more profitable alternatives (ORS) is inexpensive and antibiotics generate nearly double the profit).
    3. ORS stock-outs. Additionally, Provider misperceptions that patients do not want ORS play the biggest role in the under prescribing of ORS as estimated as 42% of under prescribing, whereas stock-outs and financial incentives explained only 6% and 5% respectively. Also, 28% providers prescribed/dispensed ORS when standardised patients expressed no preference, and 55% prescribed ORS when they expressed an ORS preference.
    Misconception drives under-prescription of ORS Science and tech
    Footer logo
    Copyright © 2015 MasterStudy Theme by Stylemix Themes
        Search